Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Tumorigenicity of pluripotent stem cells: biological insights from molecular imaging Kooreman NG; Wu JCJ R Soc Interface 2010[Dec]; 7 Suppl 6 (Suppl 6): S753-63Embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) have the ability (i) to duplicate indefinitely while maintaining pluripotency and (ii) to differentiate into cell types of all three embryonic germ layers. These two properties of ESCs and iPSCs make them potentially suitable for tissue engineering and cell replacement therapy for many different diseases, including Parkinson's disease, diabetes and heart disease. However, one critical obstacle in the clinical application of ESCs or iPSCs is the risk of teratoma formation. The emerging field of molecular imaging is allowing researchers to track transplanted ESCs or iPSCs in vivo, enabling early detection of teratomas.|Animals[MESH]|Cell Differentiation[MESH]|Embryonic Stem Cells/*pathology[MESH]|Humans[MESH]|Induced Pluripotent Stem Cells/*pathology[MESH]|Mice[MESH]|Molecular Imaging/methods[MESH]|Regenerative Medicine[MESH]|Teratoma/*pathology[MESH]|Tissue Engineering[MESH] |